GENEVA, Oct. 15 -- GENERATE BIOMEDICINES, INC. filed a patent application (US2026/023349) for “ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS THEREOF CAPABLE OF BINDING TO IL-23 AND USES THEREOF”. With publication no. WO/2026/217993, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: C07K 16/24

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....